Evidence map›Paper›PMID 14699422›Full record

ArticleMolecular psychiatry2004

Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis.

P Sklar, M T Pato, A Kirby, T L Petryshen, H Medeiros, C Carvalho, A Macedo, A Dourado, I Coelho, J Valente and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Neuregulin 2 Is a Candidate Gene for Autism Spectrum Disorder.International journal of molecular sciences · 2024
    Article
  7. Proteolytic Processing of Neuregulin 2.Molecular neurobiology · 2020
    Article
  8. Article
  9. Regulation of neural circuit formation by protocadherins.Cellular and molecular life sciences : CMLS · 2017
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. The roles of PDGF in development and during neurogenesis in the normal and diseased nervous system.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Review
  17. Article
  18. Article
  19. Association study of 83 candidate genes for bipolar disorder in chromosome 6q selected using an evidence-based prioritization algorithm.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2013
    Article
  20. ErbB4 reduces synaptic GABAA currents independent of its receptor tyrosine kinase activity.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

P SklarDepartment of Psychiatry, Harvard Medical School, and Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Charlestown, MA 02129, USA. sklar@psych.mgh.harvard.edu
M T Pato
A Kirby
T L Petryshen
H Medeiros
C Carvalho
A Macedo
A Dourado
I Coelho
J Valente
M J Soares
C P Ferreira
M Lei
A Verner
T J Hudson
C P Morley
J L Kennedy
M H Azevedo
E Lander
M J Daly
C N Pato

Funding

GENETIC ANALYSIS OF BIPOLAR DISORDERR01MH058693 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI PATO, CARLOS N · 1999 to 2003
$3.5M
GENETIC ANALYSIS OF PSYCHOSISR01MH052618 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI PATO, CARLOS N · 1997 to 2001
$1.2M
NIMH NIH HHS MH058693NIMH NIH HHS MH52618
6 · The paper itself

Abstract

Schizophrenia is a common psychiatric disorder with a complex genetic etiology. To understand the genetic basis of this syndrome in Portuguese Island populations, we performed a genome-wide scan of 29 families with schizophrenia, which identified a single region on 5q31-5q35 with strong linkage (NPL=3.09, P=0.0012 at D5S820). Empirical simulations set a genome-wide threshold of NPL=3.10 for significant linkage. Additional support for this locus in schizophrenia comes from higher-density mapping and mapping of 11 additional families. The combined set of 40 families had a peak NPL=3.28 (P=0.00066) at markers D5S2112-D5S820. These data and previous linkage findings from other investigators provide strong and consistent evidence for this genomic region as a susceptibility locus for schizophrenia. Exploratory analyses of a novel phenotype, psychosis, in families with schizophrenia and bipolar disorder detected evidence for linkage to the same markers as found in schizophrenia (peak NPL=3.03, P=0.0012 at D5S820), suggesting that this locus may be responsible for the psychotic symptoms observed in both diseases. Molecular Psychiatry (2004) 9, 213-218. doi:10.1038/sj.mp.4001418 Published online 30 December 2003

Indexed as

Chromosomes, Human, Pair 5GenomicsAzoresBipolar DisorderGenetic LinkageGenetic Predisposition to DiseaseHumansSchizophrenia

Identifiers

PMID14699422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.